Cytosorbents (CTSO) Net Cash Flow (QoQ) (2010 - 2026)

Cytosorbents (CTSO) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.03 Bn 175.74 Bn 6.27 Bn
2 Stryker 129.38 Bn 126.50 Bn 3.81 Bn
3 Medtronic 108.86 Bn 99.64 Bn 6.41 Bn
4 Boston Scientific 68.57 Bn 67.12 Bn 3.61 Bn
5 Edwards Lifesciences 47.66 Bn 43.99 Bn 1.29 Bn
6 Dexcom 28.64 Bn 27.52 Bn 750.30 Mn
7 GE HealthCare Technologies 28.55 Bn 26.27 Bn 1.98 Bn
8 Smith & Nephew 27.02 Bn 26.44 Bn -
9 Koninklijke Philips 25.54 Bn 22.42 Bn 2.07 Bn
10 Cytosorbents 23.46 Mn 18.66 Mn 6.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 54.21%
Dec 31, 2025 -4.60%
Sep 30, 2025 -53.69%
Jun 30, 2025 -149.46%
Mar 31, 2025 244.39%
Dec 31, 2024 19.68%
Sep 30, 2024 -158.13%
Jun 30, 2024 189.02%
Mar 31, 2024 -197.55%
Dec 31, 2023 217.68%
Sep 30, 2023 17.85%
Jun 30, 2023 -88.68%
Mar 31, 2023 -468.59%
Dec 31, 2022 92.67%
Sep 30, 2022 41.44%
Jun 30, 2022 -41.27%
Mar 31, 2022 -24.32%
Dec 31, 2021 -58.84%
Sep 30, 2021 -57.77%
Jun 30, 2021 -0.59%